Daiichi Sankyo/AstraZeneca Get Two Lucky Breaks For Enhertu

 
• By Alaric DeArment
  
Daiichi/Sankyo got approval for Enhertu in NSCLC, while an arbitrator ruled in DS's favor • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip